PARADIGM-HF — The Experts' Discussion

Mariell Jessup; Keith A.A. Fox; Michel Komajda; John J.V. McMurray; Milton Packer

doi:10.1056/nejmp1410203

September 4, 2014ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)

PARADIGM-HF — The Experts' Discussion

View at Publisher

Ask AI

Bookmark

Share

Why the study?

Does angiotensin-neprilysin inhibition improve outcomes compared to enalapril in advanced heart failure?

Structured PICO

Does angiotensin-neprilysin inhibition improve outcomes compared to enalapril in advanced heart failure?

P

Population

Patients with advanced heart failure

I

Intervention

Angiotensin-neprilysin inhibition

C

Comparator

Enalapril

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

An expert discussion on the PARADIGM-HF trial comparing angiotensin-neprilysin inhibition to enalapril in advanced heart failure.

Abstract

Leading cardiologists discuss PARADIGM-HF, a trial of angiotensinneprilysin inhibition versus enalapril in advanced heart failure.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jessup et al. (2014) studied this question.

synapsesocial.com/papers/6a83c28f4b7d31ae448dd081 https://doi.org/10.1056/nejmp1410203

View at Publisher

Ask AI

Bookmark

Share

PARADIGM-HF — The Experts' Discussion

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

PARADIGM-HF — The Experts' Discussion

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading